DrugPatentWatch Database Preview
Drugs in Development Information for Tivozanib
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Tivozanib?
Tivozanib is an investigational drug.
There have been 31 clinical trials for Tivozanib.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Renal Cell, and Colorectal Neoplasms. The leading clinical trial sponsors are AVEO Pharmaceuticals, Inc., National Comprehensive Cancer Network, and Astellas Pharma Inc.
Summary for Tivozanib
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 43 |
| WIPO Patent Applications | 27 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2009-12-01) |
| Vendors | 77 |
Recent Clinical Trials for Tivozanib
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma | AstraZeneca | Phase 1/Phase 2 |
| A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma | AVEO Pharmaceuticals, Inc. | Phase 1/Phase 2 |
| Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC | Bristol-Myers Squibb | Phase 1/Phase 2 |
Clinical Trial Summary for Tivozanib
Top disease conditions for Tivozanib
Top clinical trial sponsors for Tivozanib
US Patents for Tivozanib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
